DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Medical - Instruments & Supplies

Healthcare
$8.52 +1.84%

+$0.19 today

Market cap
$1.70B
Beta
0.91
P/E (TTM)
-3.3
EPS (TTM)
-$3.14
Dividend yield
6.27%
52W Low $9.41High $17.09

Volume 5.40M

Average 4.70M

XRAY Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

DENTSPLY SIRONA Inc.NASDAQ: XRAY

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense turns negative

Q1 FY2026 income tax expense was -$32M, compared with $25M a year earlier. Trailing-twelve-month income tax expense was $55M.

Context

  • Income tax expense amounted to 3.0% of revenue in FY2025, up 2.4 pp from a year earlier.
  • Income tax expense increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income tax expense holds near -$32M or moves back toward the trailing-twelve-month quarterly average of $13.75M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$32M-1500.0% QoQ
Last fiscal yearDec 2025
$112M+530.8% YoY
LTMMar 2026
$55M+466.7% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-228.0%——
1 year+530.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
112M USD
Year-over-year change
+530.8%
4-year CAGR
-4.4%

Income Tax Expense vs competitors

How XRAY compares with its peers on the latest reported figures

  • XRAY's LTM Mar 2026 income tax expense of $55M is the 3rd highest of the 4 companies compared; the peer median is $132M.
  • Its year-over-year change of +466.7% is the highest of 4, against a peer median of -15.1%.
  • Income tax expense amounts to 1.5% of revenue for XRAY, versus a peer median of 1.8%.
XRAY Competitors Peer median
Income Tax Expense for XRAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALGNAlign Technology, Inc.LTM Jun 2026$155.33M -15.1%-9.7%3.8%
HSICHenry Schein, Inc.LTM Jun 2026$132M +2.3%-9.5%1.0%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$55M +466.7%—1.5%
NVSTEnvista Holdings CorpLTM Oct 2026$50.8M -63.9%+41.6%1.8%
Peer median (excluding XRAY) $132M-15.1%-9.5%1.8%

Competitors are the stored peer set for XRAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.23B3.92B3.97B3.79B3.68B
Cost of Revenue1.88B1.8B1.88B1.84B1.84B
Gross Profit2.35B2.13B2.09B1.96B1.84B
Gross Margin55.5%54.2%52.6%51.6%50.0%
Research & Development171M174M184M165M150M
Selling, General & Admin1.55B1.59B1.61B1.61B1.44B
Operating Expenses1.74B3.06B2.17B2.84B1.59B
Depreciation & Amortization346M328M343M349M352M
EBITDA952M(662M)249M(518M)(46M)
EBITDA Margin22.5%-16.9%6.3%-13.7%-1.3%
Operating Income608M(937M)(85M)(879M)252M
Operating Margin14.4%-23.9%-2.1%-23.2%6.8%
Interest Income00000
Interest Expense61M65M81M69M88M
Other Income / Expenses(63M)(118M)(90M)(57M)(738M)
Income Before Tax545M(1.06B)(175M)(936M)(486M)
Pre-Tax Margin12.9%-26.9%-4.4%-24.7%-13.2%
Income Tax Expense134M(105M)(43M)(26M)112M
Net Income411M(950M)(132M)(910M)(598M)
Net Margin9.7%-24.2%-3.3%-24.0%-16.3%
EPS (Basic)1.88(4.41)(0.62)(4.48)(3.00)
EPS (Diluted)1.87(4.41)(0.62)(4.48)(3.00)
Weighted Avg Shares218.4M215.5M212M203.2M199.4M
Weighted Avg Shares (Diluted)220.2M215.5M212M203.2M199.4M

DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Intrinsic Alpha fair value

Locked

Current Price

$8.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.